
浏览全部资源
扫码关注微信
[ 陈洁平,E-mail: chenjp@163.com; 史春梦,E-mail: shicm@sina.com CHEN Jieping, E-mail: chenjp@163.com; SHI Chunmeng, E-mail: shicm@sina.com
收稿:2020-11-02,
修回:2020-12-29,
纸质出版:2021-01-30
移动端阅览
全军辐射医学专业委员会, 全军血液学专业委员会. 核辐射损伤造血重建策略专家共识[J]. 第三军医大学学报, 2021,43(2):175-182.
Professional Committee of Military Radiation Medicine, Professional Committee of Military Hematology. Expert consensus on hematopoietic reconstruction strategies for radiation injury[J]. Journal of Third Military Medical University, 2021, 43(2): 175-182.
全军辐射医学专业委员会, 全军血液学专业委员会. 核辐射损伤造血重建策略专家共识[J]. 第三军医大学学报, 2021,43(2):175-182. DOI: 10.16016/j.1000-5404.202011015.
Professional Committee of Military Radiation Medicine, Professional Committee of Military Hematology. Expert consensus on hematopoietic reconstruction strategies for radiation injury[J]. Journal of Third Military Medical University, 2021, 43(2): 175-182. DOI: 10.16016/j.1000-5404.202011015.
造血损伤救治是核辐射损伤救治中面临的主要挑战之一,面对大批量伤员,如何迅速准确地对造血损伤做出伤情评估与诊断,并进行快速造血重建对维护国家核安全,加强军事卫勤保障力量具有重大意义。我们通过文献检索和评价,经专家组讨论,征求全军辐射医学专业委员会及全军血液学专业委员会专家建议,制定了“核辐射损伤造血重建策略专家共识”,该共识内容包括:适用范围、核辐射造血损伤的诊断及评估、核辐射损伤造血重建的策略、展望4个部分。本共识针对核辐射的造血损伤制定救治策略,为核辐射损伤救治及军事卫勤保障提供指导和参考。
Hematopoietic injury treatment is one of the main challenges in the treatment of radiation damage. In the face of mass casualty
how to make prompt
and accurate diagnosis and evaluation for hematopoietic damage and then reconstitute hematopoiesis is of great significance to maintain the national nuclear safety and strengthen military medical support. We formulated this
Expert Consensus on Hematopoietic Reconstruction Strategy After Radiation Injury
through literature retrieval and evaluation
expert group discussion
and suggestions from the experts of our 2 professional committees. The expert consensus includes 4 parts as follow: scope of application
diagnosis and evaluation of radiation damage to hematopoietic system
hematopoietic reconstruction strategy for radiation injury
and perspective. This consensus formulates treatment strategies for hematopoietic damage caused by nuclear radiation
and provides guidance and reference for nuclear radiation damage treatment and military medical support.
LÓPEZ M, MARTÍN M. Medical management of the acute radiation syndrome[J]. Rep Pract Oncol Radiother, 2011, 16(4): 138-146. DOI: 10.1016/j.rpor.2011.05.001.
胡云轩, 刘玉龙.外照射急性放射病的特点与诊治研究现状[J].辐射防护通讯, 2019, 39(2): 34-42.
HU Y X, LIU Y L. Status of diagnosis and treatment of acute radiation sickness caused by external irradiation[J]. Radiat Prot Bull, 2019, 39(2): 34-42.
中华人民共和国卫生部.染色体畸变估算生物剂量方法: GBT28236-2011[S].北京: 中国标准出版社, 2012.
Ministry of Health of the People's Republic of China. Method of chromosome aberration analysis for biological dose assessment: GBT28236-2011[S]. Beijing: China Standard Press, 2012.
中华人民共和国卫生部.职业性外照射急性放射病诊断: GBZ104-2017[S].北京: 中国标准出版社, 2017.
Ministry of Health of the People's Republic of China. Diagnostic criteria for acute radiation sickness from external exposure: GBZ104-2017[S]. Beijing: China Standard Press, 2017.
中华人民共和国卫生部.过量照射人员医学检查与处理原则: GBZ 215-2009[S].北京: 中国标准出版社, 2019.
Ministry of Health of the People's Republic of China. Medical examination and management principle for the overexposed individuals: GBZ 215-2009[S]. Beijing: China Standard Press, 2019.
中华人民共和国卫生部.外照射事故受照人员的医学处理和治疗方案: GBT 18199-2000[S].北京: 中国标准出版社, 2000.
Ministry of Health of the People's Republic of China. Medical management and treatment programme for personnel exposed to accidental external irradiation: GBT 18199-2000[S]. Beijing: China Standard Press, 2000.
中华人民共和国卫生部.核和辐射事故伤员分类方法和标识: BZT 255-2014[S].北京: 中国标准出版社, 2014.
Ministry of Health of the People's Republic of China. Classificatoin methods and triage tag of wounded personnels in nuclear and radiation accidents: BZT 255-2014[S]. Beijing: China Standard Press, 2014.
林仲武, 王琪, 王治东.辐射生物剂量计的研究现状及发展方向[J].中华放射医学与防护杂志, 2017, 37(10): 799-804.
LIN Z W, WANG Q, WANG Z D. Overview of current situation and future development of radiation biodosimetry study[J]. Chin J Radiol Med Prot, 2017, 37(10): 799-804.
SINGH V K, SEED T M. A review of radiation countermeasures focusing on injury—specific medicinals and regulatory approval status: part Ⅰ. Radiation sub-syndromes, animal models and FDA-approved countermeasures[J]. Int J Radiat Biol, 2017, 93(9): 851-869. DOI: 10.1080/09553002.2017.1332438.
KIANG J G, OLABISI A O. Radiation: a poly-traumatic hit leading to multi-organ injury[J]. Cell Biosci, 2019, 9: 25. DOI: 10.1186/s13578-019-0286-y.
毛秉智, 陈家佩.急性放射病基础与临床[M].北京:军事医学科学出版社, 2002: 128.
MAO B Z, CHEN J P. Basic and clinical acute radiation sickness[M]. Beijing: Military Medical Science Press, 2002: 128.
SINGH V K, GARCIA M, SEED T M. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part Ⅱ. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status[J]. Int J Radiat Biol, 2017, 93(9): 870-884. DOI: 10.1080/09553002.2017.1338782.
SINGH V K, HANLON B K, SANTIAGO P T, et al . A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part Ⅲ. Countermeasures under early stages of development along with's tandard of care' medicinal and procedures not requiring regulatory approval for use[J ] . Int J Radiat Biol, 2017, 93(9): 885-906. DOI: 10.1080/09553002.2017.1332440.
HAYES-LATTIN B, LEIS J F, MAZIARZ R T. Isolation in the allogeneic transplant environment: how protective is it?[J]. Bone Marrow Transplant, 2005, 36(5): 373-381. DOI: 10.1038/sj.bmt.1705040.
DADD G, MCMINN P, MONTEROSSO L. Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience[J]. J Pediatr Oncol Nurs, 2003, 20(6): 293-300. DOI: 10.1177/1043454 203254985.
洪银慧.层流室全环境保护预防化疗后骨髓抑制期患者感染的护理分析[J].中外女性健康研究, 2019(10): 131, 165.
HONG Y H. Nursing analysis of laminar flow room environmental protection to prevent infection in patients with myelosuppression after chemotherapy[J]. Women Heal Res, 2019(10): 131, 165.
SINGH V K, SEED T M. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems[J]. Expert Opin Pharmacother, 2020, 21(3): 317-337. DOI: 10.1080/14656566.2019.1702968.
SINGH V K, ROMAINE P L P, NEWMAN V L, et al . Medical countermeasures for unwanted CBRN exposures: part Ⅱ radiological and nuclear threats with review of recent countermeasure patents[J ] . Expert Opin Ther Patents, 2016, 26(12): 1399-1408. DOI: 10.1080/13543776.2016.1231805.
戴昌世, 王秉伋.抗辐射药物研究[M].北京:军事医学科学出版社, 2003: 1-17.
DAI C S, WANG B J. Radiation medicine research[M]. Beiing: Military Medical Science Press, 2003: 1-17.
KAMRAN M Z, RANJAN A, KAUR N, et al . Radioprotective agents: strategies and translational advances[J ] . Med Res Rev, 2016, 36(3): 461-493. DOI: 10.1002/med.21386.
张蕊莹, 邢爽, 从玉文, 等.重症急性放射病防治新药研究进展[J].国际药学研究杂志, 2016, 43(3): 431-435.
ZHANG R Y, XING S, CONG Y W, et al . New drugs for treatment of severe acute radiation sickness: research advances[J ] . Foreign Med Sci Sect Pharm, 2016, 43(3): 431-435.
SINGH V K, SEED T M. The efficacy and safety of amifostine for the acute radiation syndrome[J]. Expert Opin Drug Saf, 2019, 18(11): 1077-1090. DOI: 10.1080/14740338.2019.1666104.
SINGH V K, NEWMAN V L, SEED T M. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review[J]. Cytokine, 2015, 71(1): 22-37. DOI: 10.1016/j.cyto.2014.08.003.
中华人民共和国卫生部.造血刺激因子在外照射急性放射病治疗中的应用指南: WST378-2013[S].北京: 中国标准出版社, 2013.
Ministry of Health of the People's Republic of China. Applicatoin specification of hematopoietic stimulating factor on the treatment of acute radiation sickness: WST378-2013[S]. Beijing: China Standard Press, 2013.
中华医学会血液学分会干细胞应用学组.中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅰ)—适应证、预处理方案及供者选择(2014年版)[J].中华血液学志, 2014, 35(8): 775-780.
Group of Stem Cell Application, Chinese Society of Hematology of Chinese Medical Association. The consensus of allogeneic hematopoietic transplantation for hematological diseases in China(2014)—indication, conditioning regimen and donor selection[J]. Chin J Hematol, 2014, 35(8): 775-780.
SAAD A, DE LIMA M, ANAND S, et al . Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology[J ] . JNCCN, 2020, 18(5): 599-634.
中华医学会血液学分会干细胞应用学组.中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅱ)—移植后白血病复发(2016年版)[J].中华血液学杂志, 2016, 37(10): 846-851.
Group of Stem Cell Application, Chinese Society of Hematology of Chinese Medical Association. The consensus of allogeneic hematopoietic transplantation for hematological diseases in China(2016)—post-transplant leukemia relapse[J]. Chin J Hematol, 2016, 37(10): 846-851.
中华医学会血液学分会干细胞应用学组.中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)—急性移植物抗宿主病(2020年版)[J].中华血液学杂志, 2020, 41(7): 529-536.
Group of Stem Cell Application, Chinese Society of Hematology of Chinese Medical Association. The consensus of allogeneic hematopoietic transplantation for hematological diseases in China(2020)—Acute graft versus host disease[J]. Chin J Hematol, 2020, 41(7): 529-536.
中华人民共和国卫生部.核与放射事故干预及医学处理原则: GBZ 113-2006[S].北京: 人民卫生出版社, 2007.
Ministry of Health of the People's Republic of China. Guideines on intervention and medical management in the nuclear and radiological accident: GBZ 113-2006[S]. Beijing: People's Medical Press, 2007.
邢家骝, 王桂林, 罗卫东.辐射事故临床医学处理[M].北京:军事医学科学出版社, 2006: 268.
XING J L, WANG G L, LUO W D. Clinical medicine and handling of radiation accidents[M]. Beijing: Military Medical Press, 2006: 268.
孟沛霖, 曹履先, 黄隆安, 等.两例极重度骨髓型急性放射病临床报告—上海"6.25"60 Co源辐射事故病人诊断与救治文集[C].北京: 北京科技出版社, 1994: 43-55.
MENG P L, CAO L X, HUANG L A, et al . Two cases of severe bone marrow acute radiation sickness clinical report—Shanghai "6.25" 60 Co source radiation accident patients diagnosis and treatment of corpus[C ] . Beijing: Beijing Science and Technology Press, 1994: 43-55.
中华医学会血液学分会, 中国医师协会血液科医师分会.中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2016年版)[J].中华血液学杂志, 2016, 37(5): 353-359.
Chinese Society of Hematology of Chinese Medical Association, Hematology Branch of Chinese Medical Doctor Association. Chinese guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2016)[J]. Chin J Hematol, 2016, 37(5): 353-359.
中华人民共和国卫生部.临床输血技术规范[J].中国医院, 2000, 4(6): 335-336.
Ministry of Health, PRC. Clinical blood transfusion technical specification[J]. Chin Hosp, 2000, 4(6): 335-336.
QIAN L R, CEN J. Hematopoietic stem cells and mesenchymal stromal cells in acute radiation syndrome[J]. Oxidative Med Cell Longev, 2020, 2020: 1-10. DOI: 10.1155/2020/8340756.
ZANONI M, CORTESI M, ZAMAGNI A, et al . The role of mesenchymal stem cells in radiation-induced lung fibrosis[J ] . Int J Mol Sci, 2019, 20(16): 3876. DOI: 10.3390/ijms20163876.
中华人民共和国卫生部.核和辐射突发事件心理救助导则: GBZ/T262-2014[S].北京: 中国标准出版社, 2014.
Ministry of Health of the People's Republic of China. Guidelines of psychological assistance after nuclear and radiological emergency: GBZ/T262-2014[S]. Beijing: China Standard Press, 2014.
中华人民共和国卫生部.急性放射性肺炎诊断标准: GBZ110-2002[S].北京: 中国标准出版社, 2002.
Ministry of Health of the People's Republic of China. Diagnostic criteria for acute radiation pneumonitis: GBZ110-2002[S]. Beijing: China Standard Press, 2002.
中华人民共和国卫生部.外照射急性放射病的远期效应医学随访规范: GBZ/T163-2004[S].北京: 中国标准出版社, 2004.
Ministry of Health of the People's Republic of China. Standard of long-term medical follow up of acute radiation sickness after external exposure: GBZ/T163-2004[S]. Beijing: China Standard Press, 2004.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621